12 results
Stroke and bleeding risk stratification with the CHADS2-VASc and HAS-BLED schemas

#Diagnosis #Hematology #CHADS2 #CHADS2VASc #HASBLED #Comparison
Stroke and bleeding ... risk stratification ... #Diagnosis #Hematology ... CHADS2VASc #HASBLED #Comparison ... #Bleed #Anticoagulation
Lower Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Active Bleeding

#LowerExtremity #Veins #Venous #Thrombosis
Lower Extremity Venous ... Superficial - Active Bleeding ... LowerExtremity #Veins #Venous ... Deep #VTE #DVT #Hematology ... Management #Anatomy #Anticoagulation
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Venous Thromboembolism ... points: Active bleeding ... DVT #Algorithm #Venous ... Thromboembolism #Treatment #Hematology ... #Anticoagulation
Bleeding risk calculators - HAS-BLED (atrial fibrillation) and IMPROVE (VTE prophylaxis for inpatients)
Important notes:
 • No
Bleeding risk calculators ... clinical benefit of anticoagulation ... of withholding anticoagulation ... Calculators #Anticoagulation ... #Factors #Hematology
CHA2DS2VASc vs HAS-BLED scores for stroke risk and bleed risk on anticoagulation

C	Congestive Heart Failure	1

H	Hypertension	1

A2	Age >75	2

D	Diabetes Mellitus	1

S2	Stroke,
on anticoagulation ... S Stroke 1 B Bleeding ... CHADS2VASc #HASBLED #Comparison ... #Bleed #Anticoagulation ... AFib #Diagnosis #Hematology
Helpful Clues for Distinguishing Upper vs. Lower GI Bleeding
Upper GI Bleed (proximal to ligament of Treitz):
Lower GI Bleeding ... units) • Notable risk ... Lower #GIBleed #comparison ... #versus #diagnosis ... #gastroenterology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
patients at high risk ... of bleeding. ... risk during follow-up ... Cancer #Algorithm #Anticoagulation ... #Management #Hematology
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Hemoptysis, GI Bleeding ... fatigue; Increases risk ... Potentially increases venous ... #Pharmacology #hematology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... mass index; VTE = venous ... Cancer #Algorithm #Anticoagulation ... #Management #Hematology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Longterm Venous ... PE - High Bleeding ... - Not High Bleeding ... Algorithm #management #hematology ... #anticoagulation